CXA-10 Uses, Dosage, Side Effects and more
CXA-10 is under investigation in clinical trial NCT03422510 (FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)).
| Trade Name | CXA-10 |
| Generic | CXA-10 |
| Type | |
| Formula | C18H33NO4 |
| Weight | Average: 327.465 Monoisotopic: 327.240958547 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
